2015
DOI: 10.1016/j.ejphar.2015.04.017
|View full text |Cite
|
Sign up to set email alerts
|

Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
85
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 103 publications
(88 citation statements)
references
References 51 publications
3
85
0
Order By: Relevance
“…Its main components include alkaloids and lignans. Among the alkaloids, berberine is a main active component of Rhizoma coptidis [34]. The studies found that Rhizoma coptidis can reduce weight, lower lipids [56], reduce lipid synthesis [57], and inhibit adipogenesis [58].…”
Section: Resultsmentioning
confidence: 99%
“…Its main components include alkaloids and lignans. Among the alkaloids, berberine is a main active component of Rhizoma coptidis [34]. The studies found that Rhizoma coptidis can reduce weight, lower lipids [56], reduce lipid synthesis [57], and inhibit adipogenesis [58].…”
Section: Resultsmentioning
confidence: 99%
“…For example, BBR improves myocardial dysfunction induced by hyperglycemia/hypercholesterolemia by increasing the expression of cardiac fatty acid transport proteins, fatty acid ß-oxidase, GLUT-4 and PPARγ, while decreasing PPARα expression [89], and treatment of diabetic rats with BBR improves the recovery of cardiac systolic/diastolic function and myocardial apoptosis after myocardial ischemia/reperfusion [63]. Due to its various pharmacological actions, BBR is also believed to have a potential therapeutic action on diabetic nephropathy through several mechanisms [90]. BBR improves fasting blood glucose and lipid metabolism, restores renal functional parameters, prevents structural alterations of kidney tissues and increases the levels of E prostanoid receptor 4 (EP4), reduces inflammation and the deposition of extracellular matrix in diabetic rats [90; 91].…”
Section: Type 2 Diabetesmentioning
confidence: 97%
“…Berberine, an isoquinoline‐type alkaloid, is the major active constituent, which is characterized by a diversity of pharmacological effects that have applications in different therapeutic areas . For example, berberine and its synthetic derivatives have been investigated for application in cancer and inflammation , obesity , diabetes , atherosclerosis , Alzheimer's disease , rheumatoid arthritis , and cardiovascular diseases .…”
Section: Introductionmentioning
confidence: 99%